Reported about 8 hours ago
Donald Trump has proposed imposing tariffs on imported prescription drugs to incentivize domestic manufacturing. However, health experts warn these tariffs could inadvertently raise costs, lead to shortages of generic medications, and compromise access to crucial treatments for patients. The reliance on foreign pharmaceutical production raises concerns about drug availability and national security, especially highlighted during the COVID-19 pandemic. Experts suggest that tariffs might not effectively restore domestic production and could instead exacerbate existing issues in the healthcare system.
Source: YAHOO